Rocket Doctor AI ($AIRDF): The Next 10X Healthcare Stock?

Описание: 🚀 Rocket Doctor AI ($AIDR / $AIRDF) is revolutionizing healthcare with an AI-powered platform often referred to as the “Shopify for Doctors.”

In this video, I break down:
• How I turned $ADUR into a $4M win 💰
• Why Rocket Doctor AI could be my next 10X play
• The $50M market cap vs multi-billion TAM opportunity
• Recent contracts (California Managed Care, NY Medicaid, Aetna NY)
• The GLM AI engine powering physician productivity

Timestamps
00:00 – Why microcaps can 10X
02:40 – Rocket Doctor AI explained
05:10 – $2M ARR, 89% gross margins
08:00 – Major partnerships in CA & NY
10:45 – Treatment AI acquisition + GLM advantage
14:30 – My price outlook

🔥 Don’t miss this — barely anyone in the investment community has heard of Rocket Doctor AI yet.

👉 Subscribe for more deep dives into disruptive small-cap stocks.
👉 Disclosure: Disseminated on behalf of Rocket Doctor AI. I own shares ($AIDR).

Disclaimer
Investment Publishing LLC (“We” or “Us”) are not securities dealers or brokers, investment advisers or financial advisers, and you should not rely on the information herein as investment advice. Rocket Doctor AI. issued Investment Publishing’s principal, Mariusz Skonieczny, 400,000 Options, which are each exercisable to acquire one common share of the Company at an exercise price of $0.45 for a period of three years from the date of the grant to provide marketing services for a term of 12 months. This article is informational only and is solely for use by prospective investors in determining whether to seek additional information. This does not constitute an offer to sell or a solicitation of an offer to buy any securities. Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for your further investigation; they are not stock recommendations or constitute an offer or sale of the referenced securities. The securities issued by the companies we profile should be considered high risk; if you do invest despite these warnings, you may lose your entire investment. Please do your own research before investing , including reading the companies’ SEDAR+ and SEC filings, press releases, and risk disclosures. It is our policy that information contained in this profile was provided by the company, extracted from SEDAR+ and SEC filings, company websites, and other publicly available sources. We believe the sources and information are accurate and reliable but we cannot guarantee it.
Forward Looking Statements
This article contains forward-looking statements about Rocket Doctor AI, which are identified by terms such as "anticipate," "expect," and "project." These statements reflect current views regarding company performance, business goals, healthcare market expectations, and intellectual property development. The statements are based on current business and market expectations. However, they involve various risks and uncertainties, including potential delays, financial difficulties, operational challenges, and problems protecting intellectual property. Additional risks include possible regulatory approval delays, market disruptions, personnel issues, and competitive pressures. Given these risks and uncertainties, actual results may differ significantly from what is described in the forward-looking statements. Readers should not place undue reliance on these statements, which are only valid as of the article's publication date and we undertake no obligation to update.